|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02652 CF PHARMTECH
Nominal 
23.100 +0.940 (+4.242%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 531,132 | 402,060 | 299,390 |
| Land & other Lease Assets | -- | -- | 31,165 | 28,388 | 29,071 |
| Intangible Assets | -- | -- | 121,952 | 94,934 | 75,513 |
| Interests in Asso. & JCEs | -- | -- | 1,827 | 1,901 | 0 |
| Other Non-current Assets | -- | -- | 110,734 | 112,819 | 126,980 |
| -- | -- | 796,810 | 640,102 | 530,954 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | -- | -- | 47,180 | 36,098 | 28,291 | |
| Trade Receivables | -- | -- | 27,130 | 2,870 | 8,937 | |
| Cash & Bank Balances | -- | -- | 81,937 | 70,612 | 74,838 | |
| Other Current Assets | -- | -- | 305,969 | 385,463 | 372,198 | |
| Assets Held for Sale | -- | -- | 0 | 0 | 0 | |
| -- | -- | 462,216 | 495,043 | 484,264 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 20,587 | 27,206 | 13,117 | ||
| S-T Debt & Leases | -- | -- | 20,899 | 2,713 | 1,264 | ||
| Other Current Liabilities | -- | -- | 204,122 | 141,546 | 122,808 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | 0 | ||
| -- | -- | 245,608 | 171,465 | 137,189 | |||
| Net Current Assets | -- | -- | 216,608 | 323,578 | 347,075 | ||
| Total Assets Less Current Liabilities | -- | -- | 1,013,418 | 963,680 | 878,029 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 58,198 | 19,200 | 240 | |||
| Other Non-current Liabilities | -- | -- | 15,938 | 34,457 | 15,863 | |||
| -- | -- | 74,136 | 53,657 | 16,103 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 370,780 | 370,780 | 370,780 | ||||
| Reserves | -- | -- | 568,502 | 539,243 | 491,146 | ||||
| Others | -- | -- | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 939,282 | 910,023 | 861,926 | ||||
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | ||||
| Others | -- | -- | 0 | 0 | 0 | ||||
| -- | -- | 939,282 | 910,023 | 861,926 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 108,710 | 134,366 | 143,051 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,485 |
| %Change | -88.216% |
| EPS / (LPS) | RMB 0.007 |
| NBV Per Share (¥) | RMB -- |